doi: 10.1016/s0041-1345(01)01968-6.
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience
Affiliations
- PMID: 11377471
- DOI: 10.1016/s0041-1345(01)01968-6
Item in Clipboard
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience
Transplant Proc.
2001 May.
No abstract available
Similar articles
-
Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.Transplant Proc. 1998 Dec;30(8):4087-9. doi: 10.1016/s0041-1345(98)01351-7. Transplant Proc. 1998. PMID: 9865306 Clinical Trial. No abstract available.
-
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.Clin Transplant. 2000 Apr;14(2):121-6. doi: 10.1034/j.1399-0012.2000.140204.x. Clin Transplant. 2000. PMID: 10770416 Clinical Trial.
-
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].Zhonghua Yi Xue Za Zhi. 2002 Apr 25;82(8):507-10. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12133492 Chinese.
-
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.Ann N Y Acad Sci. 2001 Jun;938:328-37; discussion 337-9. Ann N Y Acad Sci. 2001. PMID: 11458521 Review.
-
New immunosuppressants in BMT/GVHD.Transplant Proc. 2001 May;33(3):2220-2. doi: 10.1016/s0041-1345(01)01946-7. Transplant Proc. 2001. PMID: 11377507 Review. No abstract available.
Cited by
-
Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).Biol Blood Marrow Transplant. 2009 Oct;15(10):1288-95. doi: 10.1016/j.bbmt.2009.06.007. Epub 2009 Aug 3. Biol Blood Marrow Transplant. 2009. PMID: 19747637 Free PMC article.
-
Low-dose antithymocyte globulin for treatment of steroid-pulse-resistant acute graft-versus-host disease.Int J Hematol. 2003 Jan;77(1):99-102. doi: 10.1007/BF02982612. Int J Hematol. 2003. PMID: 12568309 No abstract available.
-
Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.PLoS One. 2015 Aug 31;10(8):e0136991. doi: 10.1371/journal.pone.0136991. eCollection 2015. PLoS One. 2015. PMID: 26323092 Free PMC article.
-
Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects.Immunotherapy. 2010 May;2(3):399-418. doi: 10.2217/imt.10.20. Immunotherapy. 2010. PMID: 20635904 Free PMC article. Review.
-
Secondary treatment of acute graft-versus-host disease: a critical review.Biol Blood Marrow Transplant. 2012 Jul;18(7):982-8. doi: 10.1016/j.bbmt.2012.04.006. Epub 2012 Apr 14. Biol Blood Marrow Transplant. 2012. PMID: 22510383 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
